Hosted by Nicole Sourry, Associate Director, Global Marketing and Sales at MEGIN.

Dr. Svetlana Pinet explains how MEG and AI are unlocking the mysteries of language production, and shares more about the groundbreaking Meta-BCBL research collaboration on mind-to-text communication.

Original Meta AI article: https://ai.meta.com/blog/brain-ai-research-human-communication/ Read the paper – Brain-to-text: https://ai.meta.com/research/publications/brain-to-text-decoding-a-non-invasive-approach-via-typing/ Read the paper – From thought to action: https://ai.meta.com/research/publications/from-thought-to-action-how-a-hierarchy-of-neural-dynamics-supports-language-production/

BCBL website: https://www.bcbl.eu/en

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice. *TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Please contact MEGIN for further information.

Hosted by Gabriele Richardson, Director, Global Sales and Marketing at MEGIN.

In this inspiring episode of the MEGIN Spotlights, we speak with Monika Jones, CEO and Co-Founder of the Pediatric Epilepsy Surgery Alliance - the only caregiver-led, science-driven nonprofit dedicated to enhancing the lives of children who need neurosurgery for medication-resistant epilepsy. Monika shares her personal journey as a mother of a child with epilepsy and how it led to the creation of this impactful organization. Learn how PESA empowers families through cutting-edge research, personalized support services, and critical education - before and after surgery. We explore how PESA is changing the narrative around epilepsy surgery, advocating for MEG technology, and driving global research collaborations through initiatives like the Global Pediatric Epilepsy Surgery Registry. Learn more about PESA: https://epilepsysurgeryalliance.org Global Pediatric Epilepsy Surgery Registry: https://epilepsysurgeryalliance.org/about/research/patient-registry/

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

As Medical and Scientific Directors of the hospital’s MEG lab, our guests, Professor Debopam Samanta and Assistant Professor Diana Escalona-Vargas, discuss the role of MEG in pediatric epilepsy treatment, brain tumor mapping, and neuromodulation. They share groundbreaking fetal MEG research, discuss integration with ROSA One for precision surgery, and share how Arkansas Children’s leverages MEG to advance patient care and solidify its position as a leader in pediatric neuroscience.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

We were delighted to welcome MEG Director Dr. Abbas Babajani-Feremi and Neurosurgeon Dr. Maryam Rahman from University of Florida Health. They discussed using the TRIUX™ neo in their epilepsy and brain tumor treatment programs, and shared how they make the program financially sustainable through referrals, appropriate billing, and the use of MEGIN’s internal helium recycling (IHR) technology. Additionally, our guests offered insights into emerging MEG research.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

In this Spotlight we welcome Theresa Williard, BSN, RN, CNRN, the MEG and TMS Manager at Le Bonheur Children’s Hospital. Theresa discusses how to create a successful MEG program, and how to stand out from other healthcare providers. She also shares insights into the day-to-day responsibilities of her role and Le Bonheur’s EMU program, including their sedation protocol.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

We were delighted to welcome Elaine O’Loughlin, who we were introduced to at the Pediatric Epilepsy Surgery Alliance Conference in Boston. She was kind enough to share her daughter’s experience of MEG as part of her epilepsy diagnosis and surgical planning at Boston Children’s Hospital. We hear about her family’s experience of being included in a MEG research study, how MEG data informed clinical decision making and surgical planning, and the positive changes this has had on her daughter’s epilepsy and quality of life. Elaine also shares her advice for families who are facing similar challenges.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

We were delighted to welcome our new strategic software partners FIND Neuro to the Spotlight. FIND Neuro will develop a multi-modal solution* to improve MEG utilization for pre-surgical evaluation.

On this Spotlight, we are joined by co-founders Noam Peled and Avi Yaron to discuss why FIND Neuro was created, learn more about our guests’ backgrounds and share how MEGIN and FIND Neuro intend to work together.

You can learn more at https://findsurgicalsciences.com/

*FIND Neuro is a work in progress and not available for sale.

**MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

In this Spotlight, we welcome Srikantan Nagarajan, PhD, a Professor in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. Professor Nagarajan explains how MEG technology is utilized in the brain tumor and epilepsy treatment programs at UCSF. He also offers insights on how UCSF runs a successful MEG program and achieves an ROI on this modality.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

We were delighted to welcome Caregiver Melinda Blalock to our Spotlight series. Melinda was kind enough to share her son’s epilepsy journey through 4 different pediatric hospitals, and his eventual MEG scan at Le Bonheur Children’s Hospital. We hear how the inclusion of MEG during her son’s epilepsy evaluation at Le Bonheur enabled new clinical decision making – which ultimately led to positive changes to his epilepsy, allowing for a more free and independent life with the amazing support of his family. 

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

We were delighted to welcome Simon Vogrin and Professor Chris Plummer to our Spotlight today. Together, they are the Managing Directors and co founders of EMSL, a privately run center in Melbourne which uses MEG technology in collaboration with Swinburne University of Technology.

Listen to our guests discuss the role of the EMSL center and MEG, with Professor Plummer being one of the only neurologists in Australia to incorporate MEG in patient work ups. They share specific clinical and research cases and discuss why they choose to use MEG as a part of a multi modal neuroimaging treatment plan.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.